» Articles » PMID: 38127078

Identifying Metabolic Features of Colorectal Cancer Liability Using Mendelian Randomization

Abstract

Background: Recognizing the early signs of cancer risk is vital for informing prevention, early detection, and survival.

Methods: To investigate whether changes in circulating metabolites characterize the early stages of colorectal cancer (CRC) development, we examined the associations between a genetic risk score (GRS) associated with CRC liability (72 single-nucleotide polymorphisms) and 231 circulating metabolites measured by nuclear magnetic resonance spectroscopy in the Avon Longitudinal Study of Parents and Children (N = 6221). Linear regression models were applied to examine the associations between genetic liability to CRC and circulating metabolites measured in the same individuals at age 8 y, 16 y, 18 y, and 25 y.

Results: The GRS for CRC was associated with up to 28% of the circulating metabolites at FDR-P < 0.05 across all time points, particularly with higher fatty acids and very-low- and low-density lipoprotein subclass lipids. Two-sample reverse Mendelian randomization (MR) analyses investigating CRC liability (52,775 cases, 45,940 controls) and metabolites measured in a random subset of UK Biobank participants (N = 118,466, median age 58 y) revealed broadly consistent effect estimates with the GRS analysis. In conventional (forward) MR analyses, genetically predicted polyunsaturated fatty acid concentrations were most strongly associated with higher CRC risk.

Conclusions: These analyses suggest that higher genetic liability to CRC can cause early alterations in systemic metabolism and suggest that fatty acids may play an important role in CRC development.

Funding: This work was supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol, the Wellcome Trust, the Medical Research Council, Diabetes UK, the University of Bristol NIHR Biomedical Research Centre, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computational facilities of the Advanced Computing Research Centre, University of Bristol - http://www.bristol.ac.uk/acrc/.

Citing Articles

Standardized Mortality Ratios (SMRs) and Radon Exposure Analysis for Lung Cancer and All-Cause Mortality in Locorotondo, Southern Italy.

Ferri G, De Maria L, Delvecchio G, Caputi A, Sole S, Giannelli G Medicina (Kaunas). 2025; 61(1).

PMID: 39859029 PMC: 11766524. DOI: 10.3390/medicina61010047.


A proteogenomic analysis of the adiposity colorectal cancer relationship identifies GREM1 as a probable mediator.

Lee M, Hatcher C, Hazelwood E, Goudswaard L, Tsilidis K, Vincent E Int J Epidemiol. 2025; 54(1).

PMID: 39846783 PMC: 11754674. DOI: 10.1093/ije/dyae175.


Plasma metabolite profiles related to dietary patterns: exploring the association with colorectal tumor risk.

Ni J, Lu H, Chen W, Zhao Y, Yang S, Zhang J Eur J Nutr. 2024; 64(1):13.

PMID: 39567382 DOI: 10.1007/s00394-024-03527-3.


Bacterial small molecule metabolites implicated in gastrointestinal cancer development.

Turocy T, Crawford J Nat Rev Microbiol. 2024; 23(2):106-121.

PMID: 39375475 DOI: 10.1038/s41579-024-01103-4.


[Genetic drivers for inflammatory protein markers in colorectal cancer: a Mendelian randomization approach to clinical prognosis study].

Li H, Li G, Zhang X, Wang Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(7):1361-1369.

PMID: 39051082 PMC: 11270664. DOI: 10.12122/j.issn.1673-4254.2024.07.16.


References
1.
Julkunen H, Cichonska A, Slagboom P, Wurtz P . Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife. 2021; 10. PMC: 8172246. DOI: 10.7554/eLife.63033. View

2.
Burgess S, Davies N, Thompson S . Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016; 40(7):597-608. PMC: 5082560. DOI: 10.1002/gepi.21998. View

3.
Gao R, Wu C, Xu Q . Reply. Gastroenterology. 2022; 164(4):701-702. DOI: 10.1053/j.gastro.2022.11.033. View

4.
Huyghe J, Bien S, Harrison T, Kang H, Chen S, Schmit S . Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2018; 51(1):76-87. PMC: 6358437. DOI: 10.1038/s41588-018-0286-6. View

5.
Borges M, Haycock P, Zheng J, Hemani G, Holmes M, Davey Smith G . Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using Mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants. BMC Med. 2022; 20(1):210. PMC: 9190170. DOI: 10.1186/s12916-022-02399-w. View